We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Talos Energy
TALO
$3.06B
| $18.1K | ﹤0.01% |
1,303
-512,953
| -100% | -$6.91M |
|
1777
Avita Medical
RCEL
$316M
| $18K | ﹤0.01% |
1,057
-181
| -15% | -$2.66K |
|
1778
Stewart Information Services
STC
$2.01B
| $17.9K | ﹤0.01% |
434
-317
| -42% | -$13.4K |
|
1779
Toast
TOST
$18.4B
| $17.5K | ﹤0.01% |
775
-6,477
| -89% | -$129K |
|
1780
Bowman Consulting
BWMN
$736M
| $17.4K | ﹤0.01% |
546
+48
| +10% | +$1.4K |
|
|
ARCH
1781
DELISTED
Arch Resources, Inc.
ARCH
| $17.1K | ﹤0.01% |
152
| – | – |
|
1782
Sterling Infrastructure
STRL
$14B
| $17.1K | ﹤0.01% |
307
-269
| -47% | -$11.9K |
|
1783
Barrett Business Services
BBSI
$820M
| $17.1K | ﹤0.01% |
784
-8
| -1% | -$171 |
|
|
MDRX
1784
DELISTED
Veradigm Inc. Common Stock
MDRX
| $17K | ﹤0.01% |
1,349
-585
| -30% | -$7.11K |
|
1785
MBIA
MBI
$230M
| $16.9K | ﹤0.01% |
1,956
-1,713
| -47% | -$15.4K |
|
1786
United Natural Foods
UNFI
$2.7B
| $16.5K | ﹤0.01% |
846
+558
| +194% | +$14K |
|
|
RTL
1787
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $16.5K | ﹤0.01% |
2,440
-2,136
| -47% | -$12.7K |
|
1788
Acadia Realty Trust
AKR
$2.7B
| $16.3K | ﹤0.01% |
+1,133
| New | +$15.3K |
|
1789
StoneX
SNEX
$8.06B
| $16.2K | ﹤0.01% |
+987
| New | +$17.6K |
|
|
NXGN
1790
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $16.1K | ﹤0.01% |
993
-10,081
| -91% | -$167K |
|
1791
Editas Medicine
EDIT
$404M
| $16K | ﹤0.01% |
+1,941
| New | +$16.9K |
|
1792
Park-Ohio Holdings
PKOH
$652M
| $15.8K | ﹤0.01% |
830
| – | – |
|
1793
Ameris Bancorp
ABCB
$5.69B
| $15.7K | ﹤0.01% |
459
-397
| -46% | -$13.2K |
|
1794
UFP Technologies
UFPT
$2.13B
| $15.5K | ﹤0.01% |
80
+37
| +86% | +$5.73K |
|
|
LTC
1795
LTC Properties
LTC
$2.34B
| $15.5K | ﹤0.01% |
468
+103
| +28% | +$3.44K |
|
1796
Addus HomeCare
ADUS
$2.16B
| $15.4K | ﹤0.01% |
166
-145
| -47% | -$13.8K |
|
|
TTSH
1797
DELISTED
Tile Shop Holdings
TTSH
| $15.2K | ﹤0.01% |
2,745
-941
| -26% | -$4.61K |
|
1798
Sony
SONY
$140B
| $14.9K | ﹤0.01% |
830
+230
| +38% | +$4.31K |
|
|
IMGN
1799
DELISTED
Immunogen Inc
IMGN
| $14.9K | ﹤0.01% |
789
+778
| +7,073% | +$9.19K |
|
1800
Shinhan Financial Group
SHG
$38.8B
| $14.9K | ﹤0.01% |
571
| – | – |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.